NCT01635101已完成3 期
A Randomized, Placebo Controlled, Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Mallinckrodt
- 入组人数
- 197
- 试验地点
- 22
- 主要终点
- Total Rescue Opioid Consumption
研究概览
简要总结
The purpose of this study is to demonstrate the efficacy and safety of Intravenous (IV) acetaminophen plus rescue opioids for the relief of moderate to severe acute pain in neonates and infants (age < 2 years) compared to placebo plus standard of care rescue opioids as well as characterize the concentration-effect relationship (PK/PD) of the intravenous acetaminophen as compared to the control group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 1 Day 至 2 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject is ≥ 28 weeks gestational age and < 2 years old at study enrollment
- •Subject will undergo surgery or had a traumatic injury expected to produce moderate to severe pain and patient is expected to require analgesic treatment for acute pain for 24 hours
- •Subject has a medically reasonable need for IV treatment due to their underlying procedure(s) or medical condition(s) for the duration of the study
- •Subject has reliable vascular access for administration of study medication and PK sampling
- •Subject has a bodyweight which, in the opinion of the Investigator does not preclude participation in the study.
- •Subject is free of other physical, mental, or medical conditions which, in the opinion of the Investigator, make study participation inadvisable or make it impossible to accurately assess efficacy or safety endpoints
- •Subject's parent or guardian must provide written informed consent prior to participation in the study
- •Subject's parent or guardian must have the ability to read and understand the study procedures and have the ability to communicate meaningfully with the study investigator and staff
排除标准
- •Subject is not able to comply with the sampling requirements of the study
- •Subject has known or suspected hypersensitivity to acetaminophen or the excipients of IV acetaminophen
- •Subject has any significant medical condition that in the opinion of the Investigator contraindicates participation in the study or impairs the assessment of efficacy or safety
- •Subject has participated in another interventional clinical study within 30 days of the planned study randomization date
- •Pre-Randomization (Qualification) Inclusion Criteria
- •Subject has not been administered any of the following:
- •any acetaminophen-containing product, nonsteroidal anti-inflammatory agent, central alpha-adrenergic agents (e.g., clonidine, dexmedetomidine) or ketamine within 6 hours of baseline (T0)
- •received a regional or neuraxial (caudal, epidural or spinal) anesthetic with local anesthetics within 6 hours of T0
- •Subject does not have abnormal liver function tests from a sample obtained post-operatively/post-trauma and prior to randomization above protocol-specified limits
- •Subject does not have significantly impaired renal function or known significant renal disease which in the opinion of the Investigator would contraindicate study participation.
- •Subject had a nursing assessment documenting moderate to severe pain within 6 hours prior to randomization
- •Subject required at least one dose of parenteral opioid medication for pain management (i.e., not pre-emptive therapy) during the 6-hour pre-randomization period, and is anticipated to require at least one dose of parenteral opioid medication during the 24 hour treatment period
- •If subject is breast feeding, mother has not been administered any acetaminophen containing product in the previous 6 hours to T0 and throughout the treatment period
研究组 & 干预措施
Low Dose Acetaminophen
Experimental
Participants receive a low dose of acetaminophen intravenously (IV) for 24 hours
干预措施: IV Acetaminophen (Drug)
High Dose Acetaminophen
Experimental
Participants receive a low dose of acetaminophen (IV) for 24 hours
干预措施: IV Acetaminophen (Drug)
Placebo
Placebo Comparator
Participants receive matching placebo (IV) for 24 hours
干预措施: IV Control (Drug)
结局指标
主要结局
Total Rescue Opioid Consumption
时间窗: in 24 hours
Total micrograms per kilogram (µg/kg) of rescue opioid used during the same 24 hours the subject is on study medication
次要结局
- Summary of Pain Intensity Using the LNPS in Younger Infants(within 24 hours)
- Pain Intensity Using the FLACC Score in Older Infants(within 24 hours)
- Time to First Rescue Medication(within 24 hours)
- Summary of Pain Intensity Using the Leuven Neonatal Pain Scale (LNPS) in Neonates(within 24 Hours)
- Pain Intensity Using the FLACC Score in Intermediate Aged Infants(within 24 hours)
研究者
研究点 (22)
Loading locations...
相似试验
已完成
4 期
Prospective, Double Blind, Placebo Control, Bariatric IV AceObesityNCT02452320Weill Medical College of Cornell University136
已完成
4 期
Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic SurgeryLung TumorNCT01783236Weill Medical College of Cornell University16
撤回
4 期
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Relationship Between Intraoperative Intravenous Acetaminophen and Postoperative Opioid Avoidance for Ambulatory Surgical ProceduresPostoperative PainIntraoperative and Postoperative Opioid RequirementsNCT01231191University of California, San Diego
已完成
不适用
Intraoperative and Post-operative Analgesic Effect of IV Acetaminophen for Sinus SurgeryChronic SinusitisNCT01608308The University of Texas Health Science Center, Houston62
已完成
3 期
IV Acetaminophen as Adjuvant Analgesic to Hydromorphone - Emergency Department PatientsAcute PainNCT03553498Albert Einstein College of Medicine162